microdosing glp 1 drugs GLP-1 Microdosing, Brain Health & Alzheimer's Prevention Microdosing GLP-1s: Does It Work?

MSC-Exos target ferroptosis in osteoarthritis (OA) OA is one of the most common types of musculoskeletal disorders globally [170]

N Engl J Med 362(4):329344 Knopman DS et al (2021) Alzheimer disease

BPC-157 is a synthetic research peptide widely studied in laboratory settings for its role in cellular repair, tissue regeneration, angiogenesis, and recovery-related biological processes

Higher expression of PTGS2, COX-2 and PGE2 is associated with ferroptosis induction [156], while mPGES deficiency is associated with ferroptosis inhibition [157]

Long-term data on microdosing maintenance protocols remains limited, but the clinical logic is sound and an increasing number of practitioners are adopting this approach